Our immune system is designed to protect us by recognizing and attacking infected or abnormal cells. However, cancer cells ...

A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways ...

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our ...

Phase I trial patients experienced shrinkage of brain tumors and extended survival rates beyond the standard prognosis of one ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

An engineered viral protein enhanced the anticancer function of T cells in mice, suggesting a new strategy to improve ...

Elevated LDH and higher international prognostic index were also predictors of poor outcomes on bispecific antibodies, ...

The natural process of aging occurs on a cellular level, which affects tissue and organ function. As a result, our bodies lose the ability to easily comple | Immunology ...

"CAR-γδTs represent the cutting edge of cancer therapy given the potential of such technologies to span the entirety of the immune system," stated Assistant Professor Alice Cheung, Junior Principal ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf ...